CVE:PAS Pascal Biosciences - PAS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pascal Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.02 -0.01 (-25.00%) (As of 12/5/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.02▼C$0.10Volume4,000 shsAverage Volume52,289 shsMarket CapitalizationC$983,925.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About Pascal Biosciences (CVE:PAS) StockPascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.Read More Receive PAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pascal Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PAS Stock News HeadlinesFebruary 3, 2023 | msn.comPedro Pascal Nearly Kills a Mysterious New ‘Saturday Night Live’ Cast Member in This Week’s PromoFebruary 3, 2023 | msn.comPedro Pascal’s Girlfriend History: Meet The Women He’s Been Romantically Linked To Over The YearsFebruary 3, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.February 3, 2023 | msn.comPedro Pascal Reminds Us Why He’s Daddy By Twerking With Clicker from ‘The Last of Us’ in 'SNL' PromoFebruary 3, 2023 | msn.com'The Last of Us' star Pedro Pascal's San Antonio connectionFebruary 2, 2023 | msn.comPascal Siakam Snubbed of All-Star Spot as League Announces ReservesFebruary 2, 2023 | msn.comRaptors’ Pascal Siakam All-Star snub gets hilarious one-emoji reaction by Fred VanVleetFebruary 2, 2023 | msn.comWatch Pedro Pascal grooving to Latto and Mariah Carey’s song ‘Big Energy’ on SNLFebruary 3, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.February 2, 2023 | msn.comWatch: Pedro Pascal confronts a clicker in 'SNL' promoFebruary 2, 2023 | msn.comSan Antonio claims 'The Last of Us' actor Pedro Pascal ahead of 'SNL' debutFebruary 2, 2023 | msn.comPedro Pascal Can’t Kill a ‘Last of Us’ Clicker in ‘Saturday Night Live’ PromoFebruary 1, 2023 | msn.comPedro Pascal Faces Another ‘The Last of Us’ Clicker in ‘SNL’ Promo (VIDEO)February 1, 2023 | msn.comPedro Pascal Parodies The Last of Us in First Saturday Night Live PromoFebruary 1, 2023 | msn.comPedro Pascal Is Clicker-Bait In New ‘SNL’ PromoFebruary 1, 2023 | msn.comFE: Pascal Wehrlein explains surprise at Porsche's stunning start to seasonJanuary 31, 2023 | msn.comRaptors Rumors: Gary Trent Jr, OG Anunoby, Fred VanVleet, Pascal Siakam, Nick NurseJanuary 31, 2023 | msn.comUnforgettable weekend in Diriyah leaves Pascal Wehrlein at the top of Formula E>January 30, 2023 | msn.comUnforgettable weekend in Diriyah leaves Pascal Wehrlein at the top of Formula EJanuary 30, 2023 | msn.comPedro Pascal’s net worth in 2023January 30, 2023 | msn.comWATCH: Porsche's Pascal Wehrlein takes the Formula E lead in nail-biting Saudi raceJanuary 30, 2023 | msn.comInside Pascal Siakam's All-Star case: Is Raptors forward a shoo-in for 2023 in Utah?January 28, 2023 | msn.comPascal Wehrlein's double Formula E triumph in DiriyahJanuary 28, 2023 | msn.comFE: Double Diriyah delight for Pascal Wehrlein in Saudi ArabiaJanuary 28, 2023 | msn.comThe Last of Us: Pedro Pascal and Bella Ramsey Quiz Each Other in New VideoJanuary 28, 2023 | msn.comPascal Wehrlein led Porsche to victory in DiriyahJanuary 27, 2023 | msn.comPedro Pascal's The Last of Us has been renewed for a second seasonSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pascal Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:PAS CUSIPN/A CIKN/A Webwww.biommune.net Phone+1-604-6886775FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio882.79 Current Ratio0.18 Quick Ratio0.17 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow55.00 Book ValueC($0.01) per share Price / Book-1.36Miscellaneous Outstanding Shares65,595,000Free FloatN/AMarket CapC$983,925.00 OptionableNot Optionable BetaN/A Key ExecutivesMr. Harold H. Forzley C.A. (Age 69)Chief Financial Officer Comp: $16.8kDr. Brian W. Bapty Ph.D. (Age 53)CEO, Pres & Director Mr. Kevin M. Egan M.B.A.Chief Bus. OfficerKey CompetitorsiCo TherapeuticsCVE:ICOCotinga Pharmaceuticals Inc. (COT.V)CVE:COTNaturally Splendid EnterprisesCVE:NSPMedifocus Inc. (MFS.V)CVE:MFSPacgen Life Science Co. (PBS.V)CVE:PBSView All Competitors PAS Stock - Frequently Asked Questions How have PAS shares performed in 2023? Pascal Biosciences' stock was trading at C$0.02 at the beginning of the year. Since then, PAS shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2023 here. What other stocks do shareholders of Pascal Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB), Canadian Natural Resources (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities (AQN), Aphria (APHA) and Abacus Mining & Exploration (AME). What is Pascal Biosciences' stock symbol? Pascal Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS." How do I buy shares of Pascal Biosciences? Shares of PAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Pascal Biosciences' stock price today? One share of PAS stock can currently be purchased for approximately C$0.02. How much money does Pascal Biosciences make? Pascal Biosciences (CVE:PAS) has a market capitalization of C$983,925.00. How can I contact Pascal Biosciences? Pascal Biosciences' mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The official website for the company is www.biommune.net. The company can be reached via phone at +1-604-6886775. This page (CVE:PAS) was last updated on 2/3/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.